Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Fanelli, Francesca ^a,c   Sepe, Sara ^a   D'Amelio, Marcello ^b,c   Bernardi, Cinzia ^d   Cristiano, Loredana ^e   Cimini, AnnaMaria ^e   Cecconi, Francesco ^b,f   Ceru', Maria Paola ^e   Moreno, Sandra ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acyl CoA beta oxidation; Alzheimer's disease; Brain aging; Catalase; Glutathione peroxidase; Lipid metabolism; Neurodegeneration; Oxidative stress; Peroxisome; Superoxide dismutase

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYL COENZYME A ACYLTRANSFERASE; ACROLEIN; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; CATALASE; CELL MARKER; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MITOCHONDRION; CELL FUNCTION; CELL POPULATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME INDUCTION; FEMALE; GENE MUTATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR BIOLOGY; MOUSE; MOUSE MODEL; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; MUS MUSCULUS;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ENERGY METABOLISM; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; OXIDATIVE STRESS; PEROXISOMES;

MLCS; MLOWN;

EID: 84873040431     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-8     Document Type: Article

References (87)

1. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA: Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010, 59:290-294.
2. Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010, 362:329-344.
3. Di Paolo G, Kim TW: Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 2011, 12:284-296.
4. Huang Y, Mucke L: Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
5. Walsh DM, Teplow DB: Alzheimer's disease and the amyloid β-protein. Prog Mol Biol Transl Sci 2012, 107:101-124.
6. De Duve C, Baudhuin P: Peroxisomes (microbodies and related particles). Physiol Rev 1966, 46:323-357.
7. Poirier Y, Antonenkov VD, Glumoff T, Hiltunen JK: Peroxisomal betaoxidation, a metabolic pathway with multiple functions. Biochim Biophys Acta 2006, 1763:1413-1426.
8. Wanders RJ, Waterham HR: Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006, 75:295-332.
9. Sprecher H, Luthria DL, Mohammed BS, Baykousheva SP: Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J Lipid Res 1995, 36:2471-2477.
10. Wanders RJ, Ferdinandusse S, Brites P, Kemp S: Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 2010, 1801:272-280.
11. Drago I, Giacomello M, Pizzo P, Pozzan T: Calcium dynamics in the peroxisomal lumen of living cells. J Biol Chem 2008, 283:14384-14390.
12. Lasorsa FM, Pinton P, Palmieri L, Scarcia P, Rottensteiner H, Rizzuto R, Palmieri F: Peroxisomes as novel players in cell calcium homeostasis. J Biol Chem 2008, 283: 15300-15308.
13. Titorenko VI, Terlecky SR: Peroxisome metabolism and cellular aging. Traffic 2011, 12:252-259.
14. Ribeiro D, Castro I, Fahimi HD, Schrader M: Peroxisome morphology in pathology. Histol Histopathol 2012, 27:661-676.
15. Lizard G, Rouaud O, Demarquoy J, Cherkaoui-Malki M, Iuliano L: Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. J Alzheimers Dis 2012, 29:241-254.
16. Kou J, Kovacs GG, Höftberger R, Kulik W, Brodde A, Forss-Petter S, Hönigschnabl S, Gleiss A, Brugger B, Wanders R, Just W, Budka H, Jungwirth S, Fischer P, Berger J: Peroxisomal alterations in Alzheimer's disease. Acta Neuropathol 2011, 122:271-283.
17. Santos MJ, Quintanilla RA, Toro A, Grandy R, Dinamarca MC, Godoy JA, Inestrosa NC: Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem 2005, 280:41057-41068.
18. Cimini A, Moreno S, D'Amelio M, Cristiano L, D'Angelo B, Falone S, Benedetti E, Carrara P, Fanelli F, Cecconi F, Amicarelli F, Cerù MP: Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. J Alzheimer Dis 2009, 18:935-952.
19. Cimini A, Benedetti E, D'Angelo B, Cristiano L, Falone S, Di Loreto S, Amicarelli F, Cerù MP: Neuronal response of peroxisomal and peroxisome-related proteins to chronic and acute Abeta injury. Curr Alzheimer Res 2009, 6:238-251.
20. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
21. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE: Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer 's disease. Proc Natl Acad Sci USA 2006, 103:5161-5166.
22. D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, Moreno S, Bacci A, Ammassari-Teule M, Marie H, Cecconi F: Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 2011, 14:69-76.
23. Lee SH, Kim KR, Ryu SY, Son S, Hong HS, Mook-Jung I, Lee SH, Ho WK: Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J Neurosci 2012, 32:5953-5963.
24. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ: Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
25. Schrader M, Fahimi HD: Peroxisomes and oxidative stress. Biochim Biophys Acta 2006, 1763:1755-1766.
26. Montagner A, Rando G, Degueurce G, Leuenberger N, Michalik L, Wahli W: New insights into the role of PPARs. Prostaglandins Leukot Essent Fatty Acids 2011, 85:235-243.
27. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347:645-650.
28. Chung JH, Seo AY, Chung SW, Kim MK, Leeuwenburgh C, Yu BP, Chung HY: Molecular mechanism of PPAR in the regulation of age-related inflammation. Ageing Res Rev 2008, 7:126-136.
29. Campolongo P, Roozendaal B, Trezza V, Cuomo V, Astarita G, Fu J, McGaugh JL, Piomelli D: Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. PNAS 2009, 106:8027-8031.
30. Delille HK, Alves R, Schrader M: Biogenesis of peroxisomes and mitochondria: linked by division. Histochem Cell Biol 2009, 131:441-446.
31. Bagattin A, Hugendubler L, Mueller E: Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis. Proc Natl Acad Sci USA 2010, 107:20376-20381.
32. Itoh R, Fujiki Y: Functional domains and dynamic assembly of the Peroxin Pex14p, the entry site of matrix proteins. J Biol Chem 2006, 281:10196-10205.
33. Meinecke M, Cizmowski C, Schliebs W, Kruger V, Beck S, Wagner R, Erdmann R: The peroxisomal importomer constitutes a large and highly dynamic pore. Nat Cell Biol 2010, 12:273-277.
34. van der Zand A, Gent J, Braakman I, Tabak HF: Biochemically distinct vesicles from the endoplasmic reticulum fuse to form peroxisomes. Cell 2012, 149:397-409.
35. Ahlemeyer B, Neubert I, Kovacs WJ, Baumgart-Vogt E: Differential expression of peroxisomal matrix and membrane proteins during postnatal development of mouse brain. J Comp Neurol 2007, 505:1-17.
36. Santos MJ, Kawada ME, Espeel M, Figueroa C, Alvarez A, Hidalgo U, Metz C: Characterization of human peroxisomal membrane proteins. J Biol Chem 1994, 269:24890-24896.
37. Morita M, Imanaka T: Peroxisomal ABC transporters: Structure, function and role in disease. Biochim Biophys Acta 2012, 1822: 1387-1396.
38. Moreno S, Mugnaini E, Cerù MP: Immunocytochemical localization of catalase in the central nervous system of the rat. J Histochem Cytochem 1995, 43:1253 -1267.
39. Moreno S, Nardacci R, Cerù MP: Regional and ultrastructural immunolocalization of copper-zinc superoxide dismutase in rat central nervous system. J Histochem Cytochem 1997, 45:1611-1622.
40. Qin W, Haroutunian V, Katsel P, Cardozo CP, Ho L, Buxbaum JD, Pasinetti GM: PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 2009, 66:352-361.
41. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y: Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 2008, 1216:92-103.
42. Craig MC, Murphy DG: Estrogen therapy and Alzheimer's dementia. Ann N Y Acad Sci 2010, 1205:245-253.
43. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA: A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 2011, 12:585-601.
44. Bharti P, Schliebs W, Schievelbusch T, Neuhaus A, David C, Kock K, Herrmann C, Meyer HE, Wiese S, Warscheid B, Theiss C, Erdmann R: PEX14 is required for microtubule-based peroxisome motility in human cells. J Cell Sci 2011, 124:1759-1768.
45. Pagani L, Eckert A: Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011, 2011:1-12.
46. Ferrer I: Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenerg Biomembr 2009, 41:425-431.
47. Gillardon F, Rist W, Kussmaul L, Vogel J, Berg M, Danzer K, Kraut N, Hengerer B: Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 2007, 7:605-616.
48. Gibson GE, Shi Q: A mitocentric view of Alzheimer's disease suggests multi-faceted treatments. J Alzheimers Dis 2010, 2:S591-S607.
49. Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J: Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 2010, 1347:179-185.
50. Mosconi L, Pupi A, De Leon MJ: Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci 2008, 1147:180-195.
51. Yao J, Rettberg JR, Klosinski LP, Cadenas E, Brinton RD: Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol Aspects Med 2011, 32:247-257.
52. Baarine M, Andréoletti P, Athias A, Nury T, Zarrouk A, Ragot K, Vejux A, Riedinger JM, Kattan Z, Bessede G, Trompier D, Savary S, Cherkaoui-Malki M, Lizard G: Evidence of oxidative stress in very long chain fatty acid - treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 2012, 213:1-18.
53. Zarrouk A, Vejux A, Nury T, El Hajj HI, Haddad M, Cherkaoui-Malki M, Riedinger JM, Hammami M, Lizard G: Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E). Oxid Med Cell Longev 2012, doi:10.1155/2012/623257.
54. Kane CD, Francone OL, Stevens KA: Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha. Gene 2006, 380:84-94.
55. Gray E, Ginty M, Kemp K, Scolding N, Wilkins A: Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. Eur J Neurosci 2011, 33:1421-1432.
56. Anderson EJ, Yamazaki H, Neufer PD: Induction of endogenous uncoupling protein 3 suppresses mitochondrial oxidant emission during fatty acid-supported respiration. J Biol Chem 2007, 282:31257-31266.
57. Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, Quinn J: Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 2004, 13:1225-1240.
58. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC: Lack of glutathione peroxidase-1 exacerbates αβ-mediated neurotoxicity in cortical neurons. J Neural Transm 2006, 113: 645-657.
59. Barkats M, Millecamps S, Abrioux P, Geoffroy MC, Mallet J: Overexpression of glutathione peroxidase increases the resistance of neuronal cells to Abeta-mediated neurotoxicity. J Neurochem 2000, 75:1438-1446.
60. Lubos E, Loscalzo J, Handy DE: Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011, 15:1957-1997.
61. Fujiwara N, Nakano M, Kato S, Yoshihara D, Ookawara T, Eguchi H, Taniguchi N, Suzuki K: Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem 2007, 282:35933-35944.
62. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, Hatsuta H, Murayama S, Barnham KJ, Irie K, Shirasawa T, Shimizu T: SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 2011, 286: 44557-44568.
63. Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X: The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J Neuropathol Exp Neurol 2012, 71:233-241.
64. Singh M, Nam DT, Arseneault M, Ramassamy C: Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J Alzheimers Dis 2010, 21:741-756.
65. Dang TN, Arseneault M, Murthy V, Ramassamy C: Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharmacol 2010, 3:66-78.
66. Shi R, Zhang Y, Shi Y, Shi S, Jiang L: Inhibition of peroxisomal β-oxidation by thioridazine increases the amount of VLCFAs and Aβ generation in the rat brain. Neurosci Lett 2012, 528:6-10.
67. Clark J, Simon DK: Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease. Antioxid Redox Signal 2009, 11:509-528.
68. Wenz T: Mitochondria and PGC-1α in aging and Age-associated diseases. J Aging Res 2011, 2011:1-12.
69. Zhang C, Rodriguez C, Spaulding J, Aw TY, Feng J: Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease. J Alzheimers Dis 2012, 28:655-666.
70. Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R: Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008, 33:450-458.
71. Massaad CA, Washington TM, Pautler RG, Klann E: Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009, 106:13576-13581.
72. Amenta F, Bronzetti E, Sabbatini M, Vega JA: Astrocyte changes in aging cerebral cortex and hippocampus: a quantitative immunohistochemical study. Microsc Res Tech 1998, 43:29-33.
73. Mandrekar-Colucci S, Landreth GE: Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets 2010, 9:156-167.
74. Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Hoi Yu AC: Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2011, 8:67-80.
75. Arnold G, Holtzman E: Microperoxisomes in the central nervous system of the postnatal rat. Brain Res 1978, 155:1-17.
76. Cimini A, Moreno S, Giorgi M, Serafini B, Cerú MP: Purification of peroxisomal fraction from rat brain. Neurochem Int 1993, 23:249-260.
77. Cimini A, Singh I, Farioli-Vecchioli S, Cristiano L, Cerú MP: Presence of heterogeneous peroxisomal populations in the rat nervous tissue. Biochim Biophys Acta 1998, 1425:13-26.
78. Gemma C, Vila J, Bachstetter A, Bickford PC: Oxidative stress and the aging brain: from theory to prevention. In Brain aging: models, methods, and mechanisms. Edited by Riddle DR. Boca Raton (FL): CRC Press; 2007:Chapter 15. Frontiers in Neuroscience.
79. Filomeni G, Bolaños JP, Mastroberardino PG: Redox status and bioenergetics liaison in cancer and neurodegeneration. Int J Cell Bio 2012, 2012:659645.
80. Röhl C, Armbrust E, Kolbe K, Lucius R, Maser E, Venz S, Gülden M: Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in vitro. Glia 2008, 56:1114-1126.
81. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI: Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 2000, 275:19439-19442.
82. Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H 3rd, Lovell MA, Murphy MP: RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer 's disease. PLoS One 2011, 6:1-6.
83. Moreno S, Nardacci R, Cimini A, Cerù MP: Immunocytochemical localization of D-amino acid oxidase in rat brain. J Neurocytol 1999, 28:169-185.
84. Farioli-Vecchioli S, Moreno S, Cerù MP: Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system. J Neurocytol 2001, 30:21-33.
85. Callaway E: Alzheimer's drugs take a new tack. Nature 2012, 489:13-14.
86. Selkoe DJ: Preventing Alzheimer's disease. Science 2012, 337:1488-1492.
87. Bradford MM: Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.